InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Scilex Holding Co

SCLX Clue Score30
United States Fiscal year ends December CIK 0001820190
$2.92 -1.35% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.92 −70.83% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 5 Mar 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Revenue23.6Operating income−35.3Net income−47.5EPS, diluted−0.36Fiscal year 2021Revenue31.3 +32.9%Operating income−35.8Net income−88.4EPS, diluted−0.67Fiscal year 2022Revenue38.0 +21.4%Operating income−50.6Net income−23.4EPS, diluted−0.17Fiscal year 2023Revenue46.7 +22.9%Operating income−105.4Net income−114.3EPS, diluted−1.28Fiscal year 2024Revenue56.6 +21.1%Operating income−83.4Net income−72.8EPS, diluted−8.05Fiscal year 2025Revenue30.3 −46.5%Operating income−346.0Net income−374.1EPS, diluted−36.48
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 23.6 31.3 38.0 46.7 56.6 30.3
Growth +32.9% +21.4% +22.9% +21.1% −46.5%
Operating income −35.3 −35.8 −50.6 −105.4 −83.4 −346.0
Net income −47.5 −88.4 −23.4 −114.3 −72.8 −374.1
Growth
EPS, diluted −0.36 −0.67 −0.17 −1.28 −8.05 −36.48

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2020Operating margin−149.7%Net margin−201.7%Free cash flow margin−133.6%Fiscal year 2021Operating margin−114.4%Net margin−282.4%Free cash flow margin−91.5%Fiscal year 2022Operating margin−133.1%Net margin−61.4%Free cash flow margin−55.9%Fiscal year 2023Operating margin−225.6%Net margin−244.6%Free cash flow margin−44.4%Fiscal year 2024Gross margin295.8%Operating margin−147.4%Net margin−128.7%Free cash flow margin34.2%Fiscal year 2025Gross margin415.8%Operating margin−1,143.7%Net margin−1,236.4%Free cash flow margin12.2%
FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a n/a 295.8% 415.8%
Operating margin −149.7% −114.4% −133.1% −225.6% −147.4% −1,143.7%
Net margin −201.7% −282.4% −61.4% −244.6% −128.7% −1,236.4%
Free cash flow margin −133.6% −91.5% −55.9% −44.4% 34.2% 12.2%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−31.5Capital expenditure−0.0Free cash flow−31.5Fiscal year 2021Operating cash flow−28.7Capital expenditure0.0Free cash flow−28.7Fiscal year 2022Operating cash flow−21.3Capital expenditure−0.0Free cash flow−21.3Fiscal year 2023Operating cash flow−20.7Capital expenditure−0.0Free cash flow−20.7Dividends paid−8.7Fiscal year 2024Operating cash flow19.3Capital expenditure0.0Free cash flow19.3Dividends paid−8.7Fiscal year 2025Operating cash flow3.8Capital expenditure−0.1Free cash flow3.7 −81.0%
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −31.5 −28.7 −21.3 −20.7 19.3 3.8
Capital expenditure −0.0 0.0 −0.0 −0.0 0.0 −0.1
Free cash flow −31.5 −28.7 −21.3 −20.7 19.3 3.7
Growth −81.0%
Dividends paid n/a n/a n/a −8.7 −8.7 n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2020Cash0.0Shareholders’ equity0.0Fiscal year 2021Cash4.3Total debt72.0Net cash (debt)−67.7Shareholders’ equity−223.9Fiscal year 2022Cash2.2Total debt0.0Net cash (debt)2.2Shareholders’ equity36.2Debt to equity0.00Fiscal year 2023Cash3.9Shareholders’ equity−172.9Fiscal year 2024Cash3.3Shareholders’ equity−192.6Fiscal year 2025Cash5.0Shareholders’ equity−207.8
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.0 4.3 2.2 3.9 3.3 5.0
Total debt n/a 72.0 0.0 n/a n/a n/a
Net cash (debt) n/a −67.7 2.2 n/a n/a n/a
Shareholders’ equity 0.0 −223.9 36.2 −172.9 −192.6 −207.8
Debt to equity n/a n/a 0.00 n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
23.6 31.3 38.0 46.7 56.6 30.3
Growth +32.9% +21.4% +22.9% +21.1% −46.5%
2.1 3.6 10.8 15.7 16.7 10.6
n/a n/a n/a n/a 167.4 125.8
Growth −24.9%
10.0 9.2 9.1 12.7 9.6 20.7
43.0 50.6 64.9 119.6 119.0 266.9
−35.3 −35.8 −50.6 −105.4 −83.4 −346.0
Growth
−47.6 −88.4 −23.4 −114.3 −72.8 −374.0
−0.1 0.0 0.0 0.0 −0.0 0.0
−47.5 −88.4 −23.4 −114.3 −72.8 −374.1
Growth
Per share
−0.36 −0.67 −0.17 −1.28 −7.24 −36.48
−0.36 −0.67 −0.17 −1.28 −8.05 −36.48
Growth
0.1 132.9 134.2 130.3 0.0 0.0
0.1 132.9 134.2 130.3 0.0 0.0
Growth +99,875.2% +1.0% −2.9% −100.0% +8.8%

† The diluted share count jumps at 2021 and 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 5.1% a year over five years.
  • Operating margin is down 994.1 points on five years ago, at -1,143.7%.
  • A net loss in 6 of 6 years on file.